Desai VB

No ORCID on file · 7 papers in corpus · active 2017-2026

Study types

  • other 1

Condition tags

  • endometriosis 1
2026
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1016/j.ijgc.2025.102769

Opportunistic salpingectomy reduces ovarian cancer risk. To examine heterogeneity among physicians in their adoption of opportunistic salpingectomy in hysterectomy practice, we identified 33,401 non-pregnant patients aged 18 to 49 years in …

2024
O&G open ·doi:10.1097/og9.0000000000000008

Historically, the evaluation of abnormal uterine bleeding (AUB) has involved a multi-visit process that uses a multitude of care settings (eg, in-office, imaging, laboratory), with the potential for lengthy delays in care due to the now-com…

2022
Women's health reports (New Rochelle, N.Y.) ·doi:10.1089/whr.2021.0101

BackgroundFollowing a 2014 safety warning (that laparoscopic power morcellation may increase tumor dissemination if patients have occult uterine cancer), hysterectomy practice shifted from laparoscopic to abdominal approach. This avoided mo…

2021
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2020.12.1207

BackgroundSafety warnings about power morcellation in 2014 considerably changed hysterectomy practice, especially for laparoscopic supracervical hysterectomy that typically requires morcellation to remove the corpus uteri while preserving t…

2021
Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100824

PurposeEighty percent of the approximately 500,000 hysterectomies performed annually in the US are for benign indications. There is lack of consensus regarding concurrent removal of fallopian tubes and/or ovaries. Ovarian cancer risk reduct…

other 2019
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2019.02.051

BACKGROUND: Occult uterine cancer at the time of benign hysterectomy poses unique challenges in patient care. There is large variability and uncertainty in estimated risk of occult uterine cancer in the literature and prior research often d…

2017
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2017.03.011

BackgroundThe selective estrogen receptor modulator tamoxifen is now widely used for the treatment and prevention of breast cancer. Tamoxifen use has been associated with a variety of gynecologic problems. Despite the frequency with which h…